SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-11-007538
Filing Date
2011-02-01
Accepted
2011-02-01 06:01:08
Documents
5
Period of Report
2011-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a58499e8vk.htm 8-K 13378
2 EX-99.1 a58499exv99w1.htm EX-99.1 12051
3 GRAPHIC a58499a5849900.gif GRAPHIC 4057
4 GRAPHIC a58499a5849901.gif GRAPHIC 3428
5 GRAPHIC a58499a5849902.gif GRAPHIC 2369
  Complete submission text file 0000950123-11-007538.txt   41255
Mailing Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000
Business Address 7150 MISSISSAUGA ROAD MISSISSAUGA ONTARIO A6 00000 905 286-3000
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 11561338
SIC: 2834 Pharmaceutical Preparations